Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces Fir

U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would become the first new drug approved in 20 years for patients

Related Keywords

New York , United States , Ireland , Dublin , American , Johnh Krystal , Kristin Bhavnani , Andrean Flynn , Rob Iannone , Robertl Mcneil Jr , American Psychiatric Association , Glaxosmithkline , Commission File No , Ment Health Clin , Jazz Pharmaceuticals , National Epidemiologic Survey On Alcohol , Nasdaq , Prnewswire Jazz Pharmaceuticals , Pfizer Inc , Research Triangle Park , Yale University , National Center , Drug Administration , American Psychological Association , Head Of Global Corporate Communications , Jazz Pharmaceuticals Acquires Springworks Therapeutic , Exchange Commission , Inhibitor Program , Fast Track , Statistical Manual , Mental Disorders , Clinical Global Impressions Severity , Patient Global Impression , Springworks Therapeutics , Jazz Pharmaceutical , Commission File , Jazz Pharmaceutical Quarterly Report , Global Corporate Communications , Psychiatric Association , American Psychiatric Publishing , National Epidemiologic Survey , Psychiatry Psychiatr , Post Traumatic Stress , Accessed December , Jazz , Pharmaceuticals , Nnounces , First , Patient , Unrolled , Hase , Linical , Trial , Valuating , Zp150 , Dance , Daily , Treatment , Adults , Most , Traumatic , Stress , Disorder ,